Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.
The third volume of this series features 5 chapters that cover a variety of topics including:
-Exendin-4 and its derivatives
-The growth hormone/insulin-like growth factor system
-Insulin and cardiovascular function
-Diabetes mellitus related infertility
-Adipocytokines as markers of insulin resistance
“Essential Decision Making and Clinical Judgement for Nurses 1st Edition” has been added to your cart. View cart
Frontiers in Clinical Drug Research – Diabetes and Obesity: Volume 3 1st Edition
Author(s): Atta-ur-Rahman
Publisher: Bentham Science
ISBN: 9781681082486
Edition: 1st Edition
$39,99
Delivery: This can be downloaded Immediately after purchasing.
Version: Only PDF Version.
Compatible Devices: Can be read on any device (Kindle, NOOK, Android/IOS devices, Windows, MAC)
Quality: High Quality. No missing contents. Printable
Recommended Software: Check here